0001209191-20-039407.txt : 20200630 0001209191-20-039407.hdr.sgml : 20200630 20200630131342 ACCESSION NUMBER: 0001209191-20-039407 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200626 FILED AS OF DATE: 20200630 DATE AS OF CHANGE: 20200630 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: NARACHI MICHAEL CENTRAL INDEX KEY: 0001380022 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36276 FILM NUMBER: 201001666 MAIL ADDRESS: STREET 1: C/O OREXIGEN THERAPEUTICS, INC. STREET 2: 3344 N TORREY PINES CT, #200 CITY: LA JOLLA STATE: CA ZIP: 92037 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Ultragenyx Pharmaceutical Inc. CENTRAL INDEX KEY: 0001515673 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 272546083 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 60 LEVERONI COURT CITY: NOVATO STATE: CA ZIP: 94949 BUSINESS PHONE: 415-483-8800 MAIL ADDRESS: STREET 1: 60 LEVERONI COURT CITY: NOVATO STATE: CA ZIP: 94949 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-06-26 0 0001515673 Ultragenyx Pharmaceutical Inc. RARE 0001380022 NARACHI MICHAEL C/O ULTRAGENYX PHARMACEUTICAL INC. 60 LEVERONI COURT NOVATO CA 94949 1 0 0 0 Common Stock 2020-06-26 4 A 0 2550 0.00 A 12300 D Stock Option (Right to Buy) 76.58 2020-06-26 4 A 0 4250 0.00 A 2030-06-26 Common Stock 4250 4250 D Award of Restricted Stock Units ("RSUs") under the Company's 2014 Incentive Plan. The RSUs shall vest in full on the earlier of (i) the Company's next Annual Meeting of Stockholders or (ii) June 26, 2021 The option shall vest in full on the earlier of (i) the Company's next Annual Meeting of Stockholders or (ii) June 26, 2021. /s/ Karah Parschauer, attorney-in-fact 2020-06-30